SEC Comment Letter 0000000000-24-010030 to MediWound Ltd. (MDWD)
MediWound Ltd.
Date: Sept. 5, 2024 · CIK: 0001593984 · Accession: 0000000000-24-010030
AI Filing Summary & Sentiment
File numbers found in text: 333-281843
Letter
September 5, 2024 Ofer Gonen Chief Executive Officer MediWound Ltd. 42 Hayarkon Street Yavne 8122745, Israel Re:MediWound Ltd. Registration Statement on Form F-3 Filed August 29, 2024 File No. 333-281843 Dear Ofer Gonen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Michael J. Rosenberg, Esq.
Show Raw Text
September 5, 2024
Ofer Gonen
Chief Executive Officer
MediWound Ltd.
42 Hayarkon Street
Yavne 8122745, Israel
Re:MediWound Ltd.
Registration Statement on Form F-3
Filed August 29, 2024
File No. 333-281843
Dear Ofer Gonen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Michael J. Rosenberg, Esq.